You searched for "ARN"

550 results found

Neovascular AMD: fresh recommendations underline standards of best practice

The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...

Celebrate good times, come on!

There seems to be an ever-expanding list of national and international days to celebrate some cause or event, however well-meaning or esoteric. The UN currently marks 218 international days to raise awareness on important issues. Many contorted versions exist, like...

An arm and a leg

“It cost me an arm and a leg.” – Mr B told me. An arm and a leg to be seen by the famous Russian eye surgeon who said that everybody can be spectacle-free. He took Mr B’s money (roughly...

MISS vs. conventional surgery

This was a prospective randomised parallel arm design study for 40 patients. Group 1 consisted of conventional strabismus surgery using the limbal approach and group 2 consisted of minimally invasive strabismus surgery (MISS). Mean age was 21.1±2.73 years for MISS...

Nepafenac punctal plugs after cataract surgery: a new alternative?

The nepafenac punctal plug delivery system (N-PPDS) is an experimental L-shaped plug made of nonbiodegradable, preservative-free medical-grade silicone. It can deliver a sustained level of nepafenac for six weeks. This is a prospective, randomised, parallel-arm, double-masked, placebo-controlled, phase II pilot...

Outcomes of augmented surgery for exotropia

This was a prospective study to assess patients with basic type intermittent exotropia of 15-45PD in angle and who were operated with augmented bilateral lateral rectus recessions with conjunctival recession, and followed postoperatively for six months. The study included 15...

Brolucizumab in age-related macular degeneration, HAWK Study

The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...

What's trending Feb/Mar 2024

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #ScleralTattoo #BlackEye Scleral tattoos aren’t necessarily a new phenomenon. A quick google search will identify cases being in the news from...

Touching base with Peter Holland, CEO of the IAPB

For the upcoming Eye News Dec/Jan 2025, our co-editor, David Lockington, had the opportunity to sit down with the CEO of IAPB, Peter Holland. We’re really excited to share this interview with you, which delves into Peter’s fascinating career and...

Touching base with Peter Holland, CEO of the IAPB

For the upcoming Eye News Dec/Jan 2025, our co-editor, David Lockington, had the opportunity to sit down with the CEO of IAPB, Peter Holland. We’re really excited to share this interview with you, which delves into Peter’s fascinating career and...

Artificial intelligence in glaucoma: Assessing applications instead of technology

Much is said about the potential of artificial intelligence (AI) to transform clinical practice, particularly with the advent of foundation models [1]. The newest models are ‘pretrained’ on text, image, tabular and other forms of data to produce architectures that...